MELISSA BURNS: Open Payments
NPI 1922516426 · CUMBERLAND, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$321 in 19 payments from 6 companies in 2025. Trend: 2023 $420 · 2024 $281 · 2025 $321
Food & beverage: $321
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 7 | $112 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $78 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $55 |
| Lilly USA, LLC | 2 | $28 |
| AstraZeneca Pharmaceuticals LP | 2 | $28 |
| Novo Nordisk Inc | 1 | $19 |
Products named: ELIQUIS, CAPLYTA, JARDIANCE, MOUNJARO, Wegovy, FARXIGA.
Industry payments across KY — which companies pay providers there.
